Quay Pharma is now part of
opens in a new window
opens in a new window
Latest News & Media From Quay Pharma
July 18 2022
SGS’s Quay Pharma Collaborates to Develop New Oral Medicine for Inflammatory Bowel Disease
SGS’s Quay Pharma has partnered with Intract Pharma, CPI and Pharmidex to successfully...
Read MoreJuly 12 2022
New Hampshire Pharmaceutical Development and Clinical Manufacturing Facility Nears Completion
We will soon open our Hudson, NH, pharmaceutical development and clinical manufacturing facility.
Read MoreDecember 10 2021
Acquisition Will Further Strengthen Quay Offering
Quay Pharma has been acquired by SGS, the Swiss-based world leading (TIC) Testing, Inspection and Certification company.
Read MoreMarch 22 2021
Now Recruiting in the US
Now Recruiting in the US. We have significantly extended our presence in the United States with the securing of a 55,000 sq ft facility for pharmaceutical development...
Read More
INSPECTED FACILITIES
